Info

Biophan Technologies, Inc. develops technologies for improving the performance of medical devices manufactured by third party companies, including the creation, protection and sale of intellectual property. It possesses technologies for enabling biomedical devices, both implantable and those used in diagnostic and interventional procedures, to be safe and image compatible with magnetic resonance imaging (MRI). It is also developing and marketing a system for generating power for implantable devices from body heat, and a series of implantable devices including MRI-visible vascular implants, such as a vena cava filter, a heart valve and an occluder for the treatment of atrial septal defects, a hole in the wall separating the left and right chambers of the heart. Its first licensee for several of these technologies was Boston Scientific. The Company is also a majority owner of Myotech the developer of the Myotech CSS, a circulatory support system that does not contact circulating blood.(Source: 10-K)